We are live on
!
Find out more
PM
Penbrook Management Portfolio holdings
AUM
$157M
1-Year Est. Return
46.57%
This Fund
S&P 500
This Quarter
Est. Return
+12.52%
1 Year Est. Return
+46.57%
3 Year Est. Return
+102.93%
5 Year Est. Return
+150.44%
10 Year Est. Return
–
AUM
$117M
AUM Growth
+$1.13M
(+0.97%)
Cap. Flow
-$8.43M
Cap. Flow
% of AUM
-7.18%
Top 10 Holdings %
Top 10 Hldgs %
47.01%
Holding
100
New
1
Increased
4
Reduced
49
Closed
5
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Range Resources
RRC
|
+$539K |
| 2 |
EGIO
Edgio, Inc. Common Stock
EGIO
|
+$356K |
| 3 |
Vermilion Energy
VET
|
+$252K |
| 4 |
VRN
Veren
VRN
|
+$228K |
| 5 |
CVS Health
CVS
|
+$33.8K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVO
Novo Nordisk
NVO
|
+$1.3M |
| 2 |
Apple
AAPL
|
+$829K |
| 3 |
Microsoft
MSFT
|
+$766K |
| 4 |
CNX Resources
CNX
|
+$559K |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$523K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 25.5% |
| 2 | Technology | 22.02% |
| 3 | Energy | 16.21% |
| 4 | Financials | 10.62% |
| 5 | Industrials | 8.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NVO
1
Novo Nordisk
NVO
$208B
| $21.7M | 18.47% |
320,200
-22,100
| -6% | -$1.3M |
|
|
2
Microsoft
MSFT
$3.62T
| $7.08M | 6.03% |
29,508
-3,190
| -10% | -$766K |
|
3
Amazon
AMZN
$3.06T
| $4.25M | 3.62% |
50,580
-3,600
| -7% | -$356K |
|
4
Moody's
MCO
$83.7B
| $3.83M | 3.27% |
13,750
-1,000
| -7% | -$274K |
|
5
Axcelis
ACLS
$4.03B
| $3.78M | 3.22% |
47,675
| – | – |
|
|
VRN
6
DELISTED
Veren
VRN
| $3.56M | 3.03% |
499,185
+30,680
| +7% | +$228K |
|
|
7
Vermilion Energy
VET
$1.76B
| $3.23M | 2.76% |
182,750
+12,420
| +7% | +$252K |
|
8
Thomson Reuters
TRI
$44.4B
| $3.11M | 2.65% |
25,894
-4,409
| -15% | -$508K |
|
|
9
Alphabet (Google) Class C
GOOG
$4.56T
| $2.34M | 1.99% |
26,320
-4,700
| -15% | -$449K |
|
10
Cohu
COHU
$2.31B
| $2.3M | 1.96% |
71,885
-3,600
| -5% | -$116K |
|
11
Targa Resources
TRGP
$56.8B
| $2.22M | 1.9% |
30,267
-408
| -1% | -$28.5K |
|
12
Photronics
PLAB
$1.85B
| $2.1M | 1.79% |
124,900
-800
| -0.6% | -$13.6K |
|
|
13
Alphabet (Google) Class A
GOOGL
$4.57T
| $2.09M | 1.78% |
23,700
-5,500
| -19% | -$523K |
|
14
USA Compression Partners
USAC
$3.73B
| $2M | 1.7% |
102,325
-8,300
| -8% | -$153K |
|
15
Azenta
AZTA
$1.38B
| $1.91M | 1.62% |
32,745
| – | – |
|
16
Nuveen New York Municipal Value Fund
NNY
$155M
| $1.77M | 1.5% |
213,727
| – | – |
|
17
Fidelity National Financial
FNF
$13.9B
| $1.58M | 1.35% |
42,119
-2,205
| -5% | -$82.7K |
|
18
Automatic Data Processing
ADP
$107B
| $1.51M | 1.29% |
6,338
-1,000
| -14% | -$246K |
|
19
Blackstone
BX
$108B
| $1.46M | 1.24% |
19,623
-5,000
| -20% | -$432K |
|
20
Popular Inc
BPOP
$11.1B
| $1.41M | 1.21% |
21,325
| – | – |
|
21
Data I/O
DAIO
$30.4M
| $1.39M | 1.18% |
349,750
-1,000
| -0.3% | -$3.61K |
|
22
Berkshire Hathaway Class B
BRK.B
$1.11T
| $1.23M | 1.05% |
3,987
| – | – |
|
23
Navigator Holdings
NVGS
$1.35B
| $1.2M | 1.03% |
100,650
-500
| -0.5% | -$6.08K |
|
|
24
CVS Health
CVS
$134B
| $1.15M | 0.98% |
12,341
+350
| +3% | +$33.8K |
|
|
IVAC
25
DELISTED
Intevac Inc
IVAC
| $1.15M | 0.98% |
177,700
| – | – |
|
Similar funds
IWM
EP
AC
SF
LAM
HAM
HEM
CF
Penbrook Management's Q4 2022 Portfolio in Review
As of Q4 2022, Penbrook Management held 100 positions worth $117M, up 0.97% from $116M the previous quarter. Its ten largest holdings account for 47% of the portfolio.
Penbrook Management withdrew a net $8.43M in Q4 2022, closing 5 positions and reducing 49 holdings. Its most notable exit was CNX Resources, an estimated $559K position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 25% of assets, up from 22% a quarter earlier, followed by Technology and Energy.
Against the trend, Penbrook Management opened a new position in Range Resources worth $493K.
- Penbrook Management's largest Q4 2022 buy was Range Resources: 19,700 shares worth $493K.
- Penbrook Management added most to Edgio, Inc. Common Stock in Q4 2022, an estimated $356K increase.
- Penbrook Management's biggest Q4 2022 reduction was Novo Nordisk, cutting an estimated $1.3M.
- Penbrook Management fully exited CNX Resources in Q4 2022, selling an estimated $559K.
- Penbrook Management's ten largest holdings make up 47% of its $117M portfolio in Q4 2022.
- Penbrook Management opened 1 new position and closed 5 in Q4 2022.
- Penbrook Management's portfolio value rose 0.97% quarter-over-quarter to $117M.
Based on Penbrook Management's 13F filing for Q4 2022, filed 24 Jan 2023.